Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sino Harbour Holdings Group is a diversified company with core operations in real estate development and an expanding presence in healthcare, particularly through its subsidiaries focused on pharmaceutical inspection, contract research organization services, and stem cell technology. The group has entered into multiple strategic partnerships with hospitals and biotech companies to build out its healthcare portfolio, including the establishment of joint ventures targeting the creation of world-class stem cell industrial bases. Its life science activities are primarily at the service/platform level rather than direct drug development or commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sino Harbour Holdings Group.